Biodesix nets $8.3 mln in Series E financing
Biodesix said Monday that it has raised $8.3 million in Series E financing from existing unnamed investors. Based in Boulder, Colorado, Biodesix is a molecular diagnostics company.
2 December 2013•2 mins read
